![]() However, employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information, unless the disclosure is (a) in response to a formal complaint or charge, (b) in furtherance of an investigation, proceeding, hearing, or action, including an investigation conducted by the employer, or (c) consistent with the contractor’s legal duty to furnish information. Stryker Corporation will not discharge or in any other manner discriminate against employees or applicants because they have inquired about, discussed, or disclosed their own pay or the pay of another employee or applicant. If you’d like more information on your rights under the law, please see the following notices: Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, or protected veteran status. Before that she served as company group chairman for the worldwide. Stryker Corporation is an equal opportunity employer. New York, which is suing Endo and other drugmakers alongside the states Nassau and Suffolk counties, sought default judgment in a motion on Sunday, saying that documents produced mid-trial. McHugh was the chief executive officer of Nora Therapeutics, Inc. In this role, she is responsible for the strategic direction and operations of Endo’s corporate compliance program. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process due to a disability, please email This contact information is for accommodation requests only and cannot be used to inquire about the status of applications. Dubas is Senior Vice President and Chief Compliance Officer, effective October 2016. Stryker Corporate endeavors to make this site accessible to any and all users. 19, 2020/CNW/ - Endo International plc(NASDAQ: ENDP) today announced it has agreed to acquire all of the outstanding shares of BioSpecifics Technologies Corp.(NASDAQ: BSTC), a commercial-stage biopharmaceutical company, for 88. Before providing any personal information to outside parties, please verify the following: A) all legitimate Stryker recruiter email addresses end with and B) the position described is found on our careers site at. ![]() ![]() Stryker has become aware of a fraud where unknown entities are posing as Stryker recruiters in an attempt to obtain personal information from individuals as part of our application or job offer process. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |